| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/14/2001 | CA2393588A1 Solid oral dosage form |
| 06/14/2001 | CA2393539A1 Radioactive compositions and methods of use thereof |
| 06/14/2001 | CA2393530A1 Pharmaceutical compositions for oral use |
| 06/14/2001 | CA2393526A1 Nucleic acid delivery system |
| 06/14/2001 | CA2392295A1 Compositions including ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | CA2391995A1 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | CA2391944A1 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/14/2001 | CA2391828A1 Process for preparing ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | CA2389013A1 Compositions including ether-capped poly(oxyalkylated) alcohol wetting agents |
| 06/14/2001 | CA2388828A1 Topical anesthetic formulation |
| 06/14/2001 | CA2362606A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | CA2361563A1 Use of polyacrylamide gel for forming a connective-tissue capsule in a mammal for cultivating allogenic or xenogenic cells |
| 06/13/2001 | EP1106646A1 Excipient and disintegrant composition, process for obtaining the same and its use |
| 06/13/2001 | EP1106599A1 Chromium l-threonate, process for preparation of the same and their use |
| 06/13/2001 | EP1106177A1 Tumor tissue accumulation enhancers for drugs |
| 06/13/2001 | EP1106081A1 Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
| 06/13/2001 | EP1106068A2 Process for preparing an emulsifier-containing powder |
| 06/13/2001 | EP1105518A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS |
| 06/13/2001 | EP1105467A1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 06/13/2001 | EP1105409A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 06/13/2001 | EP1105401A1 Phosphoglycolipid and methods for its use |
| 06/13/2001 | EP1105399A1 Carboxylated phosphatidic acid esters |
| 06/13/2001 | EP1105161A2 Phosphorylated polymers and conjugates thereof |
| 06/13/2001 | EP1105142A2 Blood-brain barrier therapeutics |
| 06/13/2001 | EP1105139A1 Ophthalmic solution with tetracycline for topical treatment of dry eye disease |
| 06/13/2001 | EP1105123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 06/13/2001 | EP1105122A1 Pharmaceutical compositions containing lipase inhibitors |
| 06/13/2001 | EP1105114A1 Nimesulide containiing topical pharmaceutical compositions |
| 06/13/2001 | EP1105111A1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 06/13/2001 | EP1105110A1 Spray on bandage and drug delivery system |
| 06/13/2001 | EP1105109A1 Injectable formulations of nanoparticulate naproxen |
| 06/13/2001 | EP1105107A1 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 06/13/2001 | EP1105105A1 Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles |
| 06/13/2001 | EP1105104A1 Extended release buccal bioadhesive tablet |
| 06/13/2001 | EP1105102A1 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt |
| 06/13/2001 | EP1105100A1 Alginate capsules for use in the treatment of brain tumour |
| 06/13/2001 | EP1105099A2 Fish gelatinous composition for use as an ingredient in tablets |
| 06/13/2001 | EP1105098A1 Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient |
| 06/13/2001 | EP1105097A2 Targeted vesicular constructs for cytoprotection and treatment of h.pylori infections |
| 06/13/2001 | EP1105096A1 Injectable aqueous dispersions of propofol |
| 06/13/2001 | EP1105095A2 Biodegradable microparticles gel composition |
| 06/13/2001 | EP1105094A1 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 06/13/2001 | EP1105089A1 Gel-based cosmetic composition |
| 06/13/2001 | EP1007021B1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone |
| 06/13/2001 | EP0967975B1 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/13/2001 | EP0886474B1 Caramels containing a sweetener |
| 06/13/2001 | EP0877598B1 Anthelmintic paste |
| 06/13/2001 | EP0831727B1 Fat substitutes containing water soluble beta-caroten |
| 06/13/2001 | EP0825876B1 Composition and method of enhancing electrotransport agent delivery |
| 06/13/2001 | EP0814778B1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 06/13/2001 | EP0797432B1 Oil-in-water emulsions |
| 06/13/2001 | EP0789562B1 Sustained release caffeine formulation |
| 06/13/2001 | EP0743851B1 Lipophilic carrier preparations |
| 06/13/2001 | EP0710103B1 Pharmaceutical compositions for hardly soluble active substances |
| 06/13/2001 | EP0687174B1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation |
| 06/13/2001 | EP0686034B1 Bisacodyl dosage form |
| 06/13/2001 | EP0678019B1 Enhanced solubility pharmaceutical solutions |
| 06/13/2001 | EP0651765B1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
| 06/13/2001 | DE19957688A1 New conjugates comprising a cis-platinum compound coupled to a nonimmunogenic protein through a carbonyl, thiocarbonyl or sulfoxide bridge, useful for treating tumors and inflammation |
| 06/13/2001 | DE19957371A1 Mitomycin C-Lösung Mitomycin C solution |
| 06/13/2001 | CN1299291A Implantable particles for tissue bulking and the treatment of gastroesophageal reflux diosease |
| 06/13/2001 | CN1299290A High viscosity liquid controlled delivery system as a Device |
| 06/13/2001 | CN1299289A Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
| 06/13/2001 | CN1299286A Use of protease inhibitors for treating skin wounds |
| 06/13/2001 | CN1299277A Pharmaceutical compositions contg. the phospholipase inhibitor sodium [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy] acetate |
| 06/13/2001 | CN1299273A Sticking plaster for controlled release of natural interferon |
| 06/13/2001 | CN1299256A Steam generating pad |
| 06/13/2001 | CN1299234A Method and compounds for the genetic treatment of hyperlipidemia |
| 06/13/2001 | CN1298881A Solid, stable and concentrated type ortho-silicis acid complex based on bio-absorption, and its prepn. method |
| 06/13/2001 | CN1298707A Montmorillonite as new medical material |
| 06/13/2001 | CN1066964C Microcapsules, method of making same and their use |
| 06/13/2001 | CN1066930C Cholesterol lowering drink mixture compositions |
| 06/12/2001 | US6245901 Modified polypeptide |
| 06/12/2001 | US6245811 Fatty acid esters as bioactive compounds |
| 06/12/2001 | US6245805 Coadministering a taxane and a cyclosporin |
| 06/12/2001 | US6245788 Using 5-aryl-1,2,4-triadazol-3-yl (thio)urea compound |
| 06/12/2001 | US6245785 Dissolution of triprolidine hydrochloride |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245752 Antigenic carbohydrate determinant; anticarcinogenic agents |
| 06/12/2001 | US6245750 Thymidine phosphoramide derivative; antiproliferative, anticarcinogenic agents; enzyme inhibitors; |
| 06/12/2001 | US6245747 Targeted site specific antisense oligodeoxynucleotide delivery method |
| 06/12/2001 | US6245740 Polyol:oil suspensions for the sustained release of proteins |
| 06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 06/12/2001 | US6245735 Conjugate of antibiotic and polypeptide of cystic fibrosis transmembrane conductance regulator or lipopolysaccharide binding fragment |
| 06/12/2001 | US6245568 Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
| 06/12/2001 | US6245537 Removing endotoxin with an oxdizing agent from polyhydroxyalkanoates produced by fermentation |
| 06/12/2001 | US6245427 Non-ligand polypeptide and liposome complexes as intracellular delivery vehicles |
| 06/12/2001 | US6245359 Active agent transport systems |
| 06/12/2001 | US6245358 Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation |
| 06/12/2001 | US6245357 Extended release dosage form |
| 06/12/2001 | US6245356 Mixture of amorphous drug, wetting agent, sustained release excipients and diluents |
| 06/12/2001 | US6245355 Sustained release matrix for high-dose insoluble drugs |
| 06/12/2001 | US6245354 Drug delivery system using galactoxyloglucan |
| 06/12/2001 | US6245353 Mixing with effervescent base |
| 06/12/2001 | US6245346 Pharmaceutical compositions for the sustained release of insoluble active principles |
| 06/12/2001 | US6245334 Polypeptide containing lecithin |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/12/2001 | CA2223780C Fat substitutes containing water soluble beta-carotene |
| 06/12/2001 | CA2168007C Drug delivery agents incorporating mitomycin |
| 06/12/2001 | CA2085366C Novel polyamines and method for preparation thereof |